首页> 外文期刊>中德临床肿瘤学杂志(英文版) >金属硫蛋白在三种女性肿瘤内表达的临床意义
【24h】

金属硫蛋白在三种女性肿瘤内表达的临床意义

机译:金属硫蛋白在三种女性肿瘤内表达的临床意义

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To study the expressions and significations of metallothionein (MT) in cervical squamous cell cancer (CSC), bladder transitional cell cancer (BTC) and breast cancer (BC) of woman. Methods: Immunohistochemical method was used to examine the expresses rate of MT in three types of woman cancer tissue. Results: The expressions rates of MT were 54.35% (29/46) in BTC, 67.05% (59/88) in BC and 57.14% (40/70) in CSC. The positive rate of MT expression was higher in low differentiation group than well differentiation group in BTC and CSC (P < 0.05). Positive of MT in lobular cancer was significance higher than medullary and duct cancers (P < 0.05). Conclusion: The expression of MT is related to differentiation degree, and it is a guidance for clinical choice of chemotherapy project.
机译:目的:研究宫颈鳞状细胞癌(CSC),膀胱移行细胞癌(BTC)和乳腺癌(BC)的宫颈鳞状蛋白(MT)的表达和义务。方法:使用免疫组织化学方法检查三种妇女癌组织中MT的表达率。结果:BTC的MT的表达率为54.35%(29/46),在BC的67.05%(59/88),CSC中的57.14%(40/70)。低分分化组的Mt表达阳性率高于BTC和CSC中的孔分化基团(P <0.05)。小叶癌中的MT阳性高于髓质和管道癌症(P <0.05)。结论:MT的表达与分化程度有关,它是化疗项目临床选择的指导。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号